Australia leads on psychedelic therapy but Monash expert urges caution amid global hype

Psychedelic therapy is gaining momentum, and Australia is framed as a leading place for research and development, but a Monash expert warns against hype-driven overreach. The core message is caution: promising clinical work should not be treated as proof that psychedelic treatments are ready for broad, uncontrolled use. The article emphasizes that real-world adoption depends on evidence quality, clinical safety, proper regulation, and careful patient screening and monitoring, especially given how quickly public attention can outpace data.